--- a
+++ b/clusters/9knumclustersv2/clust_1402.txt
@@ -0,0 +1,80 @@
+Patients requiring any daily supplemental oxygen
+Subject requires continuous supplemental oxygen for any reason. Additional Exclusion Criteria for Arm B
+Requirement for daily supplemental oxygen
+Clinically significant pulmonary compromise, including a requirement for supplemental oxygen use to maintain adequate oxygenation.
+Clinically significant pulmonary compromise, including a requirement for supplemental oxygen use to maintain adequate oxygenation.
+Participant has a need for supplemental oxygen with the exception of using previously existing non-invasive continuous positive airway pressure (CPAP) at night.
+Subjects with a history of interstitial lung disease; patients requiring continuous supplemental oxygen are excluded to avoid possible complications from pneumonitis
+ARM  - A: Pulmonary: patients with a requirement for supplemental oxygen or evidence of moderate-severe COPD by PFTs are permitted to enroll
+Patients with baseline respiratory insufficiency severe enough to require supplemental oxygen.
+Patients requiring ventilator support or oxygen supplementation exceeding % fraction of inspired oxygen (FiO) within  days of enrollment.
+Research participant requires supplemental oxygen to keep saturation greater than % and the situation is not expected to resolve within  weeks
+Research participant does not require supplemental oxygen to keep saturation greater than % and/or does not have presence of any radiographic abnormalities on chest x-ray that are progressive
+Clinically-significant pulmonary compromise, including a requirement for supplemental oxygen use to maintain adequate oxygenation
+Oxyhemoglobin saturation at rest >= % (off supplemental oxygen)
+Pulmonary dysfunction defined as:\r\n* Severe pulmonary dysfunction with () a hemoglobin corrected DLCO < % of predicted at the Baseline Screening visit, or () FVC < % of predicted Baseline Screening visit, or\r\n* Partial pressure (pO) <  mmHg or pCO >=  mmHg without supplemental oxygen, or \r\n* O saturation < % at rest without supplemental oxygen as measured by forehead pulse oximeter
+Patients requiring oxygen therapy
+Patients requiring oxygen therapy
+Patients requiring continuous supplemental oxygen are excluded to avoid possible complications from pneumonitis
+Need for supplemental oxygen
+No supplemental oxygen requirement
+Patient is on supplemental home oxygen
+ADDITIONAL CRITERIA FOR STUDY CONTINUATION: Patient is on supplemental home oxygen
+Research participant does not require supplemental oxygen to keep saturation greater than % and/or does not have presence of any radiographic abnormalities on chest x-ray that are progressive
+Research participant requires supplemental oxygen to keep saturation greater than % and the situation is not expected to resolve within  weeks
+Within  days of study registration: No oxygen requirement on room air or requiring =< L supplemental oxygen (O)
+Current use of supplemental oxygen
+Clinically-significant pulmonary compromise, including a requirement for supplemental oxygen use to maintain adequate oxygenation.
+Any patient requiring supplemental oxygen therapy
+Respiratory insufficiency with oxygen requirement >  L nasal cannula
+Patients must not require daily supplemental oxygen
+No history of severe chronic obstructive pulmonary disease (COPD) or emphysema or interstitial lung disease currently on home supplemental oxygen; patients with NSCLC with stable COPD or emphysema not requiring supplemental oxygen are eligible
+No requirement for supplemental oxygen therapy
+Severe hypoxemia with room air pulmonary arterial oxygen tension (PaO) < , supplemental oxygen dependence, or DLCO < % predicted
+Patients requiring supplemental oxygen
+Participants requiring any daily supplemental oxygen
+Patients requiring supplemental oxygen therapy
+Patient is on supplemental home oxygen
+Patients on supplemental home oxygen
+May not be on supplemental oxygen
+Patient must not have a requirement for supplemental oxygen
+Requirement of supplemental oxygen.
+History of interstitial pneumonitis and/or require supplemental oxygen therapy
+Requiring supplemental oxygen at more than  L/min
+Dyspnea of any cause requiring supplemental oxygen therapy;
+Participants requiring any daily supplemental oxygen
+Patients with history of lung disease currently requiring any pharmacologic or supplemental oxygen treatment
+Adequate pulmonary function defined as:\r\n* No dyspnea at rest\r\n* No known requirement for supplemental oxygen\r\n* No known active pneumonitis
+Clinically significant pulmonary hypertension, as defined by the requirement for ongoing pharmacologic treatment or the consistent or intermittent use of supplemental home oxygen.
+Patient currently requiring supplemental oxygen for his/her daily life
+Requirement for supplemental oxygen to carry out activities of daily living
+Patients with active infection defined as:\r\n* Positive blood culture within  hours of study registration\r\n* Need for supplemental oxygen or vasopressors within  hours of study entry
+Oxygen saturation <% on room air by trans-cutaneous method or need for any supplemental oxygenation or ventilatory support, or increase in oxygen supplementation requirement of ? litres for subjects with chronic oxygen dependency. For those subjects with a history of chronic hypoxia (without supplemental oxygen), an oxygen saturation of at least % below the patient's historical baseline oxygen saturation will satisfy this criterion.
+Oxygen saturation < % despite supplemental oxygen >  L/minute.
+Daily supplemental oxygen
+Subjects currently on supplemental oxygen support
+Patients with history of lung disease currently requiring any pharmacologic or supplemental oxygen treatment
+Chronic supplemental oxygen requirement or hypoxemia < % blood oxygen saturation (SpO)
+Any patients requiring oxygen at baseline
+Currently requiring high flow oxygen for oxygenation
+Supplemental oxygen dependency
+Supplemental oxygen requirement >  L per minute
+Patients requiring oxygen more than  liters
+No requirement for supplemental oxygen (O)
+Patients with history of lung disease currently requiring any supplemental oxygen treatment
+Clinically significant pulmonary compromise (e.g. require supplemental oxygen)
+Adequate pulmonary function as assessed by oxygen saturation >= % when ambulating and not requiring supplemental oxygen
+Respiratory disease requiring continuous supplemental oxygen
+Supplemental oxygen requirement >  L per minute
+Supplemental oxygen requirement >  L per minute
+Oxygen saturation < % despite supplemental oxygen >  L/min
+Severe hypoxemia with room air partial pressure of oxygen (PaO) < , supplemental oxygen dependence, or DLCO < % predicted
+Hypoxemia (less than % saturation with supplemental oxygen)
+Current use of supplemental oxygen
+Significant valvular disease, or significant pulmonary disease requiring supplemental oxygen therapy
+Patients that require supplemental oxygen are excluded
+Patients requiring continuous supplemental oxygen due to the requirement of spirometry during all imaging studies
+Patients with history of lung disease currently requiring any pharmacologic or supplemental oxygen treatment
+Requires daily supplemental oxygen.
+Patients that require supplemental oxygen are excluded
+Oxygen saturation >= % when ambulating and not requiring supplemental oxygen